Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703725 | SCV000522615 | likely benign | not provided | 2019-07-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000867248 | SCV001008452 | benign | Charcot-Marie-Tooth Neuropathy X | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004022362 | SCV002751324 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-07-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002502521 | SCV002812441 | likely benign | Arts syndrome; Hearing loss, X-linked 1; Charcot-Marie-Tooth disease X-linked recessive 5; Phosphoribosylpyrophosphate synthetase superactivity | 2021-09-29 | criteria provided, single submitter | clinical testing |